Kamada Ltd
Company Profile
Business description
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Contact
2 Holzman Street
P.O. Box 4081
Science Park
Rehovot7670402
ISRT: +972 89406472
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
374
Stocks News & Analysis
stocks
Ask the analyst: How reliant are Guzman shares on international growth?
stocks
Nvidia: Back in business in China; Raising fair value estimate
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,863.70 | 47.30 | 0.54% |
CAC 40 | 7,722.09 | 44.12 | -0.57% |
DAX 40 | 24,009.38 | 50.91 | -0.21% |
Dow JONES (US) | 44,254.78 | 231.49 | 0.53% |
FTSE 100 | 8,926.55 | 11.77 | -0.13% |
HKSE | 24,514.44 | 3.32 | -0.01% |
NASDAQ | 20,730.49 | 52.69 | 0.25% |
Nikkei 225 | 39,728.48 | 65.08 | 0.16% |
NZX 50 Index | 12,912.72 | 158.13 | 1.24% |
S&P 500 | 6,263.70 | 19.94 | 0.32% |
S&P/ASX 200 | 8,612.30 | 50.50 | 0.59% |
SSE Composite Index | 3,506.94 | 3.16 | 0.09% |